Key takeaway: During the Q1 FY26-27 earnings conference call held on August 1, 2026, management reported a steady performance despite geopolitical headwinds affecting raw material supply chains. The company achieved its highest ever consolidated sales of approximately INR 264 crores, with a 7% sequential revenue growth. Standalone revenue improved by 5% to INR 203 crores, driven by increased product realization. EBITDA and PAT margins were reported at 43% and 36%, respectively. Management highlighted the successful scale-up of the HALS business, which now constitutes 22% of sales, and noted a strategic collaboration with Geneus Chem to enhance HALS offerings. The company also announced a long-term contract with Kemin for key ingredients, ensuring supply security. Management indicated that operational efficiencies and higher-grade product sales would contribute to sustained EBITDA margin improvements. The call concluded with management expressing confidence in navigating supply chain challenges moving forward.

Key takeaway: The investor presentation for Clean Science and Technology Limited for the quarter ended June 30, 2026, reported steady performance despite global challenges. The company incurred approximately Rs. 100 crores in capital expenditure during the quarter, primarily for investment in its wholly owned subsidiary, Clean Fino Chem Ltd. Management highlighted the establishment of a European subsidiary to enhance global presence and customer engagement. The presentation noted that the company achieved its highest-ever consolidated sales, with total revenue reaching INR 268 crores, an 8% increase year-over-year. The revenue mix showed a significant contribution from performance chemicals, which accounted for 81% of total sales. Management emphasized ongoing strategic collaborations and product diversification efforts, including the successful commercialization of new products. The document also outlined the company's commitment to sustainability and corporate governance, underscoring its zero-debt status and strong financial metrics.

Key takeaway: On May 14, 2026, Clean Science and Technology Limited held its Q4 FY26 earnings conference call, where management reported a resilient quarter despite ongoing global challenges. The company experienced an 8% quarter-on-quarter revenue increase to INR 193 crores, driven by higher customer offtake, although year-on-year sales declined by 19%. Consolidated revenues rose 14% to approximately INR 246 crores. Management highlighted strong performance in the HALS segment, achieving record revenue, and noted a strategic focus on backward integration to enhance operational efficiency. The Promoter Directors voluntarily reduced their performance bonuses for FY26 to less than 1% of PBT. The company also announced a final dividend of INR 4 per equity share. Management discussed ongoing capex projects and the stabilization of new plants, indicating a commitment to improving productivity and efficiency.

Key takeaway: The investor presentation from Clean Science and Technology Limited, dated May 14, 2026, provided an update on the company's financial performance for Q4 FY2026 and the full fiscal year. Management reported a total revenue of INR 197 crore for Q4 FY2026, reflecting a 6% increase quarter-on-quarter but a 20% decrease year-on-year. The EBITDA margin improved to 45.6%, up from 40.3% in the previous quarter. For FY2026, total revenue was INR 815 crore, down 12% from FY2025. The company incurred a capital expenditure of approximately INR 220 crore, primarily for investments in its subsidiary, Clean Fino Chem Ltd. The Board approved a final dividend of INR 4 per share, resulting in a total payout ratio of 25%. The presentation emphasized the company's commitment to sustainability and innovation, highlighting its zero-debt status and strong cash balance.

Key takeaway: The investor presentation from Clean Science and Technology Limited provided an overview of the company's financial performance for Q4 FY2026 and the full fiscal year. Management reported a total revenue of INR 197 crore for Q4 FY2026, reflecting a 6% increase quarter-on-quarter but a 20% decrease year-on-year. The EBITDA margin improved to 45.6% in Q4 FY2026, up from 40.3% in the previous quarter. For FY2026, total revenue was INR 815 crore, a 12% decline from FY2025. The company incurred a capital expenditure of approximately INR 220 crore during FY2026, primarily for investments in its subsidiary, Clean Fino Chem Ltd. The Board approved a final dividend of Rs. 4 per share, resulting in a total payout ratio of 25% for the year. The presentation emphasized the company's commitment to sustainability and innovation, highlighting its zero-debt status and strong cash balance.

Key takeaway: The earnings conference call for Clean Science and Technology Limited on January 31, 2026, highlighted a challenging business environment marked by muted customer demand, pricing pressures, and tariff uncertainties. Management reported a year-on-year revenue decline of 21% and a quarter-on-quarter revenue moderation to INR180 crores, primarily due to lower sales volumes in established products. However, the HALS business showed a robust year-on-year growth of 55%. The company achieved EBITDA breakeven in its subsidiary Clean Fino Chem Limited and announced an interim dividend of INR2 per share. Management discussed ongoing capital expenditures, including the commercialization of a hydroquinone and catechol plant, and emphasized a focus on customer engagement and long-term growth despite current market challenges. The call concluded with management expressing commitment to improving margins and revenues while navigating macroeconomic factors.